MONOSHOT HA + PRP

MONOSHOT HA + PRP

Products
MONOSHOT HA + PRP
MONOSHOT HA + PRP

Information

MONOSHOT is a procedure pack intended for intra-articular injection of hyaluronic acid (HA) enriched with platelet-rich plasma (PRP). MONOSHOT provides the simultaneous lubricating and shock-absorbing effect of hyaluronic acid with optimally selected physicochemical parameters as well as the regenerative effect of growth factors secreted by platelets contained in PRP, obtained with the use of separation device. Intra-articular injection of hyaluronic acid of 3.8 ml, 2.5% with PRP brings the stronger effect, because of the combined effect of the ingredients.
Main Categories
BiopharmaceuticalsFinished Dosage FormsPharmaceutical Machinery & Technology
All Categories
BiopharmaceuticalsFinished Dosage FormsInjectablesMedical DevicesPharmaceutical Machinery & TechnologyRegenerative Medicine
Distribution areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from
Poland
BiovicoBiovico is a biotechnology and pharmaceutical company focused on researching and developing new innovative and rigorously tested products, manufacturing in the highest GMP level quality and providing with comprehensive and holistic solutions to professionals and patients around the world. From inception in 2008 R&D was a clear focus, understanding that the most important and lasting effects can come only through scientific endeavour. Very soon the first HA product Biolevox family was developed and the line continued to grow and expand in terms of indications for use and viability, obtaining a very significant share of the Polish orthopedic market. Further products related to autologous blood derived platelet rich plasma - Xerthra family and multiple others. It has led to progress and development in multiple fields with pharmaceutical, medical devices and biofermentation. 15 years on the market, nearly 50 countries all around the world, over 200 employees, Biovico has finished several clinical studies for unique products and started many others. With Multiple patents to its name, company's fields of expansion and increasing revenues are the staple of good business. Expanding both in terms of reach to new markets and in man-power at R&D, creating new exciting departments offering services including contract manufacturing, increasing production capacity by 500%, creating a logistics center and both organic and non-organic growth in M&A processes. Unique products include Lipotris, Wint, Monoshot, Hyrac, Progum - provide most exciting new solutions.

Log in

See all the content and easy-to-use features by logging in or registering!